measuregroup/AID464021

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103739778_AID464021_PMID20104851_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103739780_AID464021_PMID20104851_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103739848_AID464021_PMID20104851_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID464021_PMID20104851_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103739781_AID464021_PMID20104851_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103739777_AID464021_PMID20104851_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition of P-glycoprotein-mediated in absence of test compound multidrug resistance in human doxorubicin-resistant K562 cells assessed as doxorubicin cytotoxic IC50 to doxorubicin cytotoxic IC50 in presence of test compound at 1 uM after 72 hrs by MTT assay
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103739777 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103739781 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103739780 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103739848 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103739778 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID464021

Total number of triples: 17.